Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics Combined With Budesonide in Primary IgA Nephropathy
NCT06528015Phase 4Not yet recruiting
- Start
- Jul 2024
- Primary completion
- Dec 2026
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 4 trial of Lactobacillus casei Zhang in IgA nephropathy (IgAN). Planned start Jul 2024; status: not yet recruiting.
02
Drugs
Lactobacillus casei Zhang
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT06528015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06528015.